California Stem Cell Treatment Center, Inc. v. United States
Certiorari Denied
Petition for certiorari denied on October 14, 2025.
Issue
(1) Whether stem cells removed, isolated, and then reimplanted in a patient’s own stem cells to promote natural healing via surgical procedure are “drugs” subject to regulation under the Food Drug and Cosmetic Act; and (2) whether, if so, the Food and Drug Administration had a lawful basis for an enforcement action to prevent prevent physicians from undertaking the procedure given the FDA's own “same surgical procedure” exception to the Act.
Feb 11, 2025Application (24A784) to extend the time to file a petition for a writ of certiorari from March 20, 2025 to May 19, 2025, submitted to Justice Kagan.
Feb 14, 2025Application (24A784) granted by Justice Kagan extending the time to file until May 19, 2025.
May 19, 2025Petition for a writ of certiorari filed. (Response due June 20, 2025)Jun 9, 2025Waiver of right of respondent United States to respond filed.Jun 17, 2025DISTRIBUTED for Conference of 9/29/2025.
Jun 18, 2025Motion for leave to file amicus brief filed by Goldwater Institute. (Distributed)Jun 20, 2025Brief amicus curiae of Association of American Physicians and Surgeons filed. (Distributed)Oct 6, 2025DISTRIBUTED for Conference of 10/10/2025.
Oct 14, 2025Motion for leave to file amicus brief filed by Goldwater Institute DENIED.
Oct 14, 2025Petition DENIED.
Recommended Citation: California Stem Cell Treatment Center, Inc. v. United States, SCOTUSblog, https://www.scotusblog.com/cases/california-stem-cell-treatment-center-inc-v-united-states/